New Enterprise Associates 12, Limited Partnership has an estimated net worth of $867 Million. This is based on reported shares across multiple companies, which include OPOWER, INC., Workday, Inc., FUSION-IO, INC., TriVascular Technologies, Inc., HYPERION THERAPEUTICS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Tintri, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., ARDELYX, INC., SUNESIS PHARMACEUTICALS INC, Liquidia Technologies Inc, PEPLIN INC, ARYx Therapeutics, Inc., HEMOSENSE INC, and Echo Global Logistics, Inc..

2014 was New Enterprise Associates 12, Limited Partnership's most active year for acquiring shares with 22 total transactions. New Enterprise Associates 12, Limited Partnership's most active month to acquire stocks was the month of June. 2014 was New Enterprise Associates 12, Limited Partnership's most active year for disposing of shares, totalling 30 transactions. New Enterprise Associates 12, Limited Partnership's most active month to dispose stocks was the month of June. 2015 saw New Enterprise Associates 12, Limited Partnership paying a total of $23,518,351.15 for 2,794,565 shares, this is the most they've acquired in one year. In 2015 New Enterprise Associates 12, Limited Partnership cashed out on 2,384,221 shares for a total of $109,674,166.00, their largest year based on trade value.